Key Drivers Reshaping the Cardiogenomics Testing Panels Market: Rising Prevalence Of Inherited Cardiovascular Diseases Driving The Market Growth Due To Advances In Genetic Testing And Early Diagnosis Industry Transformation

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cardiogenomics Testing Panels Market Size Growth Forecast: What to Expect by 2025?
Recent years have seen a swift expansion in the cardiogenomics testing panels market size. Projected to ascend from $1.38 billion in 2024 to $1.55 billion by 2025, the market is expected to experience a compound annual growth rate (CAGR) of 12.7%. The growth observed in historical periods is credited to factors including the enhancement of reimbursement policies for genetic tests, an increase in genetic counseling services, a heightened focus on early diagnosis and prevention, vibrant public awareness campaigns, and the broader adoption of telehealth and remote diagnostic measures.

How Will the Cardiogenomics Testing Panels Market Size Evolve and Grow by 2029?
Over the approaching years, the market for cardiogenomics testing panels is projected to experience swift growth, eventually reaching a value of $2.48 billion in 2029, reflecting a compound annual growth rate (CAGR) of 12.4%. The projected growth during this period can be linked to an upsurge in cardiovascular diseases, an increased awareness of genetic predilections, an expanding demand for personalized medicine, more availability of next-generation sequencing, and enhanced health care investments in genomics. Key trends to watch in this forecast period encompass progress in next-generation sequencing, the application of artificial intelligence in data interpretation, evolution of multi-gene panels, improvements in microarray technology, and the fusion of genomic data with electronic health records.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiogenomics-testing-panels-global-market-report

What Drivers Are Propelling the Growth of Cardiogenomics Testing Panels Market Forward?
The cardiogenomics testing panels market is predicted to grow, fueled by the rising prevalence of inherited cardiovascular diseases. These diseases, a collection of heart and blood vessel conditions passed on genetically from parent to child, are seeing an increase due to improved genetic testing and diagnostics. This allows for more precise detection of cases that would otherwise remain undiagnosed. Cardiogenomics testing panels contribute to managing these conditions by analyzing a patient's genetics to detect mutations responsible for hereditary heart conditions. Early identification enables risk assessment and tailored treatment plans. For example, the Joint Strategic Needs Assessment reported 185 deaths from cardiovascular disease in Blackpool in 2023, a rise from 178 deaths in 2022, hence driving the cardiogenomics testing panels market. Growth in the cardiogenomics testing panels market is expected to be stimulated by the increasing amount of resources invested in healthcare. This expenditure, encompassing the funds deployed by governments, private entities, and individuals for the provision, upkeep, and advancement of health services and care, is growing due to the increasing chronic disease incidence. These conditions require continuous surveillance, extended treatment, and expert medical interventions. Through funding genetic analyses, healthcare expenditure aids cardiogenomics testing panels in providing early detection and prevention of inherited cardiovascular diseases, enhancing patient conditions and curtailing long-term expenses. For instance, the Centers for Medicare & Medicaid Services reported that the US healthcare spending grew by 4.1% in 2022, reaching a sizable $4,500 billion, a rise from a 3.2% growth in 2021, thus fueling the cardiogenomics testing panels market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28157&type=smp

What Are the Key Segments in the Cardiogenomics Testing Panels Market?
The cardiogenomics testing panels market covered in this report is segmented as

1) By Product Type: Single-Gene Panels, Multi-Gene Panels, Whole Exome Sequencing Panels
2) By Technology: Next-Generation Sequencing, PCR-Based Testing, Microarray, Other Technologies
3) By Application: Inherited Cardiovascular Diseases, Arrhythmias, Cardiomyopathies, Congenital Heart Diseases, Other Appications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:
1) By Single-Gene Panels: Ion Channel Gene Panels, Structural Heart Disease Gene Panels, Arrhythmia Gene Panels
2) By Multi-Gene Panels: Cardiomyopathy Panels, Arrhythmia Panels, Congenital Heart Disease Panels
3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels, Comprehensive Exome Panels, Research-Oriented Exome Panels

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28157&type=smp

Who Are the Key Players Shaping the Cardiogenomics Testing Panels Market's Competitive Landscape?
Major companies operating in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

What Geographic Markets Are Powering Growth in the Cardiogenomics Testing Panels Market?
North America was the largest region in the cardiogenomics testing panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics testing panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28157

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.